Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 410

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 410
---
, the present value of right-to-use assets and lease liabilities,
and the valuation allowance associated with deferred tax assets. Actual results could differ from those estimates.

Cash, restricted cash, and cash equivalents– The Company considers all highly liquid investments with an original maturity from the date of purchase of three months or
less to be cash equivalents. As of December 31, 2023 and 2022, cash and cash equivalents consist of cash deposited with banks, including
a money market sweep account. Restricted cash consists of $79,756 held on account by a financial institution as collateral for a demand
letter of credit issued as a real estate security deposit.

<div align='center'>F-55

CERo Therapeutics, Inc.

Notes to Financial Statements</div>

Concentration of credit risk– Financial
instruments that potentially subject the Company to credit risk consist primarily of cash, restricted cash, and cash equivalents. The
Company’s cash, restricted cash, and cash equivalents are on deposit with two financial institutions that management believe are
of sufficiently high credit quality. Deposits at any of the Company’s financial institutions may, at times, exceed federal insured
limits.

Property and equipment– Property
and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the respective assets, generally three to five years or the remaining lease term for leasehold improvements, if shorter.
Expenditures for repairs and maintenance are charged to expense as incurred. Upon disposition, the cost and related accumulated depreciation
are removed from the accounts and the resulting gain or loss is reflected in the statements of operations.

Impairment of long-lived assets–
The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. When such an event occurs, management determines whether there has been an impairment by comparing the
anticipated undiscounted future net cash flows to the related asset’s carrying value. If an asset is considered impaired, the asset
is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature
of the asset. Through December 31, 2023, the Company has not experienced any impairment losses on its long-lived assets.

Leases –The Company determines
if an arrangement contains a lease at inception. A lease is an operating or financing contract, or part of a contract, that conveys the
right to control the